By proceeding, you agree to our Terms of Use and Privacy Policy.
Drug discovery remains an expensive and time-consuming process. Promising compounds proceed through clinical trials only to have many fail before FDA approval.
24-26 May 2022
With TCEs being studied in both hematological and solid tumors (39 and 34 trials respectively), there are now more than one hundred projects in the preclinical stage.
Event Ended
USA
Paid
Boston